Logo Sertox

Portal latinoamericano de toxicología

High levels of resistance in the common bed bug, to neonicotinoid insecticides, study

28 January, 2016
Bed bugs have developed resistance to neonicotinoids. eurekalert.org. January 28, 2016.A new study published in the Journal of Medical Entomology is the first to report that bed bugs have developed resistance to a class of insecticides known as neonicotinoids, or neonics, the shortened name. Neonics are the most widely used group of insecticides today, and several products have been developed for bed bug control over the past few years that combine neonics with pyrethroids, another class of insecticide.Read related:  Posttreatment feeding affects mortality of bed bugs exposed to insecticides, study
High levels of resistance in the common bed bug, to neonicotinoid insecticides, study

CAPTION

This is a bed bug (Cimex lectularius).

CREDIT

U.S. Centers for Disease Control (CDC)

USAGE RESTRICTIONS

None

Dr. Alvaro Romero from New Mexico State University and Dr. Troy Anderson from Virginia Tech collected bed bugs from human dwellings in Cincinnati and Michigan and exposed them to four different neonics: acetamiprid, dinotefuran, imidacloprid, and thiamethoxam. They also applied these neonics to a bed bug colony kept by Dr. Harold Harlan for more than 30 years without any insecticide exposure, and to a pyrethroid-resistant population from Jersey City that had not been exposed to neonics since they were collected in New Jersey in 2008.
Unsurprisingly, the Harlan bed bugs died even when exposed to very small amounts of the neonics. The Jersey City bed bugs fared slightly better, showing moderate resistance to acetamiprid and dinotefuran, but not to imidacloprid or thiamethoxam.
The authors believe that the detection of neonicotinoid resistance in the Jersey City bed bugs, which were collected before the widespread use of neonics, could be due to pre-existing resistance mechanisms. When exposed to insecticides, bed bugs produce "detoxifying enzymes" to counter them, and the researchers found that the levels of detoxifying enzymes in the Jersey City bed bugs were higher than those of the susceptible Harlan population.
"Elevated levels of detoxifying enzymes induced by other classes of insecticides might affect the performance of newer insecticides," said Dr. Romero.
The bed bugs from Michigan and Cincinnati, which were collected after combinations of pyrethroids and neonicotinoids were introduced to the U.S. market, had even higher levels of resistance to neonics.
It only took 0.3 nanograms of acetamiprid to kill 50 percent of the non-resistant bed bugs from Dr. Harlan’s lab, but it took more than 10,000 nanograms to kill 50 percent of the Michigan and Cincinnati bed bugs. Just 2.3 nanograms of imidacloprid was enough to kill 50 percent of the Harlan bed bugs, but it took 1,064 and 365 nanograms to kill the Michigan and Cincinnati bed bugs, respectively. The numbers were similar for dinotefuran and thiamethoxam.
Compared to the Harlan control group, the Michigan bed bugs were 462 times more resistant to imidacloprid, 198 times more resistant to dinotefuran, 546 times more resistant to thiamethoxam, and 33,333 times more resistant to acetamiprid.
The Cincinnati bed bugs were 163 times more resistant to imidacloprid, 226 times more resistant to thiamethoxam, 358 times more resistant to dinotefuran, and 33,333 times more resistant to acetamiprid.
"Companies need to be vigilant for hints of declining performance of products that contain neonicotinoids," Dr. Romero said. "For example, bed bugs persisting on previously treated surfaces might be an indication of resistance. In these cases, laboratory confirmation of resistance is advised, and if resistance is detected, products with different modes of action need to be considered, along with the use of non-chemical methods."
###
The full article, "High Levels of Resistance in the Common Bed Bug, Cimex lectularius (Hemiptera: Cimicidae), to Neonicotinoid Insecticides," is available at http://jme.oxfordjournals.org/lookup/doi/10.1093/jme/tjv253.
The Journal of Medical Entomology is published by the Entomological Society of America, the largest organization in the world serving the professional and scientific needs of entomologists and people in related disciplines. Founded in 1889, ESA today has nearly 7,000 members affiliated with educational institutions, health agencies, private industry, and government. Members are researchers, teachers, extension service personnel, administrators, marketing representatives, research technicians, consultants, students, and hobbyists. For more information, visit http://www.entsoc.org.

____________________________________________________________________________________________________Read also: Bedbugs develop resistance to widely used chemical treatments, rendering them ineffective.eurekalert.org. Janury 28, 2016. This is the first study to show that overuse of certain insecticides has led to an increased resistance to the compounds, making them much less effective than advertised.One of the most of the most widely used commercial chemicals to kill bedbugs are not effective because the pesky insects have built up a tolerance to them, according to a team of researchers from Virginia Tech and New Mexico State University.

CAPTION

It turns out, the insecticides used to kill bedbugs don’t even scratch the surface, a study by Virginia Tech and New Mexico State University found.

CREDIT

Virginia Tech

USAGE RESTRICTIONS

Credit: Virginia Tech

Millions of dollars have been spent on insecticides to kill the bugs that have wreaked havoc on everything from hotels in New York City to homes in Los Angeles. But this is the first study to show that overuse of certain insecticides has led to an increased resistance to the compounds, making them much less effective than advertised.
"While we all want a powerful tool to fight bed bug infestations, what we are using as a chemical intervention is not working as effectively it was designed and, in turn, people are spending a lot of money on products that aren’t working," said Troy Anderson, an assistant professor of entomology in the Virginia Tech College of Agriculture and Life Sciences.
Anderson and Alvaro Romero, an assistant professor of entomology at New Mexico State University, published their findings in the Journal of Medical Entomology on Thursday.
The two examined the class of insecticides called neonicotinoids, or neonics, which is often paired with pyrethroids in commercial applications to treat bedbugs.
"Companies need to be vigilant for hints of declining performance of products that contain neonicotinoids," Romero said. "For example, bedbugs persisting on previously treated surfaces might be an indication of resistance."
The researchers conducted their study by comparing bedbugs from homes in Cincinnati and Michigan that had been exposed to neonics with a colony that a researcher has kept isolated since before the insecticide was used. For the last 30 years, the colony has been in an isolated lab run by Harold Harlan with the Armed Forced Pest Management Board.
They also examined a pyrethroid-resistant population from New Jersey that had not been exposed to neonics since they were collected in 2008.
The bedbugs from Harlan’s lab that never have been exposed to neonics died when they were exposed to a very small amount of the insecticide. The New Jersey bedbugs fared slightly better, showing moderate resistance to four different types of neonics.
But the bedbugs from Michigan and Cincinnati, which were collected after combinations of insecticides were introduced to the U.S., had much higher levels of resistance to neonics.
It only took 0.3 nanograms of a substance called acetamiprid to kill 50 percent of the nonresistant bedbugs from Harlan’s lab — but it took more than 10,000 nanograms to kill 50 percent of the Michigan and Cincinnati bedbugs.
Just 2.3 nanograms of another substance called imidacloprid was enough to kill 50 percent of Harlan’s bedbugs, but it took 1,064 nanograms to kill the Michigan bedbugs and 365 nanograms to kill the Cincinnati bedbugs.
Compared with the Harlan control group, the Michigan bedbugs were 462 times more resistant to imidacloprid, 198 times more resistant to dinotefuran, 546 times more resistant to thiamethoxam, and 33,333 times more resistant to acetamiprid.
The Cincinnati bedbugs were 163 times more resistant to imidacloprid, 226 times more resistant to thiamethoxam, 358 times more resistant to dinotefuran, and 33,333 times more resistant to acetamiprid.
The researchers believe that the detection of neonicotinoid resistance in the New Jersey bedbugs, which were collected before the widespread use of neonics, could be due to pre-existing resistance mechanisms.
When exposed to insecticides, bedbugs produce "detoxifying enzymes" to counter them, and the researchers found that the levels of detoxifying enzymes in the New Jersey bedbugs were higher than those of the susceptible Harlan population.
"Unfortunately, the insecticides we were hoping would help solve some of our bed bug problems are no longer as effective as they used to be, so we need to reevaluate some of our strategies for fighting them," said Anderson, who is also a researcher at the Fralin Life Science Institute.
"If resistance is detected, products with different modes of action need to be considered, along with the use of non-chemical methods," said Romero.
###
The full article, "High Levels of Resistance in the Common Bed Bug, Cimex lectularius (Hemiptera: Cimicidae), to Neonicotinoid Insecticides," is available at http://jme.oxfordjournals.org/lookup/doi/10.1093/jme/tjv253.  
Add more content here...